CORT.US
id: 585, Created by Stan Vick, Scout
Corcept Therapeutics (CORT) $14M Securities Settlement
How it works?
- Company agreed to settle with investors to avoid further litigation
- We prepare documents and claim payout for you
N.D. California
Court3:19-CV-01372
Case number02 Aug 2017
Class period Start31 Jan 2019
Class period EndCorcept Therapeutics (CORT) agreed to settle $14 million with investors to end a securities class action lawsuit over concealing that it improperly paid doctors to promote its drug Korlym and inflated its revenue and sales using illicit sales practices through a related party.
Investors who bought $CORT or call options to purchase common stock of Corcept between August 2, 2017, through January 31, 2019, inclusive, may be entitled to a payout.
Alleged Offence
Misleading Statements,
Financial Misrepresentation,
Failure to Disclose,
Omissions
Suspected Party
Directors,
Management
Security Type
Stocks
Trade Direction
Long
Payout per Share
0.06
Filing date
14 March 2019
Lead Plaintiff Deadline
13 May 2019
Plaintiffs
Ferraro Family Foundation
Attorneys
Levi & Korsinsky, LLP (San Francisco, CA)
Defendants
Joseph K. Belanoff, Charles Robb, Sean Maduck
Judge
Hon. Lucy H. Koh
Administrator
A.B. Data Ltd
Settlement agreement date
2023-04-11
Trades matching type
FIFO
+$14,000,000
Total Settlement Amount